Does TYSABRI Cause Central nervous system lesion? 116 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 116 reports of Central nervous system lesion have been filed in association with TYSABRI. This represents 1.4% of all adverse event reports for TYSABRI.
116
Reports of Central nervous system lesion with TYSABRI
1.4%
of all TYSABRI reports
1
Deaths
17
Hospitalizations
How Dangerous Is Central nervous system lesion From TYSABRI?
Of the 116 reports, 1 (0.9%) resulted in death, 17 (14.7%) required hospitalization, and 1 (0.9%) were considered life-threatening.
Is Central nervous system lesion Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TYSABRI. However, 116 reports have been filed with the FAERS database.
What Other Side Effects Does TYSABRI Cause?
Multiple sclerosis relapse (811)
Fatigue (759)
Malaise (523)
Gait disturbance (445)
Multiple sclerosis (443)
Memory impairment (422)
Headache (368)
Drug ineffective (329)
Asthenia (328)
Fall (324)
What Other Drugs Cause Central nervous system lesion?
FINGOLIMOD (2,416)
DIMETHYL (1,152)
INTERFERON BETA-1A (978)
NATALIZUMAB (627)
DALFAMPRIDINE (561)
GLATIRAMER (492)
TERIFLUNOMIDE (315)
ADALIMUMAB (229)
OFATUMUMAB (185)
RITUXIMAB (151)
Which TYSABRI Alternatives Have Lower Central nervous system lesion Risk?
TYSABRI vs TYVASO
TYSABRI vs UBIDECARENONE
TYSABRI vs UBLITUXIMAB
TYSABRI vs UBLITUXIMAB-XIIY
TYSABRI vs UBROGEPANT